Admera Health develops pharmacogenomics next-generation sequencing arrays that predict effective treatment and dosages of more than three hundred different drugs, deliver personalized results, and decrease the risk of adverse drug effects while expediting effective patient treatment.
When the company expanded its commercial lab operations, it needed new capabilities to interact with patients, providers, and payors as well as to manage accessions, and create and distribute reports. The organization’s leaders wanted to retain the current laboratory information management system (LIMS) used for the technical processing of specimens and integrate new LIS capabilities into the existing infrastructure.
Admera Health chose XIFIN LIS because it integrates into the organization’s existing technologies while providing the flexible, cloud-based workflow management system needed to support the operations of molecular and pharmacogenomic laboratories.
Admera Health is an advanced molecular diagnostics company focused on personalized medicine, non-invasive cancer testing and digital health. Dedicated to developing cutting-edge diagnostics that span the continuum of care, Admera Health fulfills unmet medical needs with cost-effective tests and accurate analysis to guide patient care.
South Plainfield, New Jersey
Laboratory Information System